Bruker

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bruker and other ETFs, options, and stocks.

About BRKR

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST).

CEO

Frank H. Laukien

CEOFrank H. Laukien

Employees

11,396

Employees11,396

Headquarters

Billerica, Massachusetts

HeadquartersBillerica, Massachusetts

Founded

1960

Founded1960

Employees

11,396

Employees11,396

BRKR Key Statistics

Market cap

5.79B

Market cap5.79B

Price-Earnings ratio

69.10

Price-Earnings ratio69.10

Dividend yield

0.55%

Dividend yield0.55%

Average volume

3.60M

Average volume3.60M

High today

$38.73

High today$38.73

Low today

$36.52

Low today$36.52

Open price

$36.82

Open price$36.82

Volume

2.96M

Volume2.96M

52 Week high

$64.64

52 Week high$64.64

52 Week low

$28.53

52 Week low$28.53

BRKR News

Simply Wall St 12h

The Bull Case For Bruker Could Change Following Major Federally Funded NMR Orders Announcement

Bruker Corporation recently announced that it secured approximately US$10 million in new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation fr...

Simply Wall St 2d

Bruker: Exploring Current Valuation After Recent Market Volatility

Bruker (BRKR) has experienced a period of volatility in its stock performance recently, with shares rising about 3% over the past month while still remaining do...

TipRanks 3d

Bruker Inc: Promising Product Launches Amid Market Uncertainties Lead to Hold Rating

Bruker, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Daniel Brennan from TD Cowen maintained a Hold rating on the stock...

Analyst ratings

54%

of 13 ratings

Buy

53.8%

Hold

38.5%

Sell

7.7%

People also own

Based on the portfolios of people who own BRKR. This list is generated using Robinhood data, and it’s not a recommendation.